February 23, 2013
RIKEN Researcher to Discuss Breakthrough in the Development of Killer T Lymphocytes at the 2nd Annual Cancer Immunotherapy Conference in Washington DC
In the first US presentation of their discovery, Raul Vizcardo, Ph.D, will discuss RIKEN Research Center’s breakthrough in creating cancer-specific, immune system cells called killer T lymphocytes, from induced pluripotent stem cells (iPS cells) at the 2nd Annual Cancer Immunotherapy Conference in Washington DC on April 4-5, 2013, hosted by Arrowhead Publishers and Conferences.